Business News • PR NewsWire • Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines

Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines

Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines

SHANGHAI, Aug. 29, 2019 /PRNewswire/ -- Luye Pharma Group (02186.HK) released its financial results for the first half of 2019 on August 28. The results show the company has achieved a revenue of RMB 3.131 billion, up 42.1% year-on-year; EBITDA reached RMB 1.263 billion, up 44.1%...

View More : https://www.prnewswire.com:443/news-releases/luye-pharma-first-half-of-2019-results-strong-revenue-growth-and-substantia...

Releted News by prnewswire